methylprednisolone has been researched along with bromocriptine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abhay, K; Castot, A; Lange, F; Maurel, C; Melon, E; Schaeffer, A | 1 |
| Majid, H; Zubair, UB | 1 |
| Ajduk, J; Košec, A; Kruljac, I | 1 |
| Kataria, S; Khan, E; Kramer, J; Moreno-Escobar, MC; Niaze, F; Peshwe, K; Sriwastava, S; Subedi, R; Tandon, M | 1 |
2 review(s) available for methylprednisolone and bromocriptine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
Topics: Adult; Anti-Inflammatory Agents; Bromocriptine; COVID-19; Dopamine Agonists; Humans; Male; Methylprednisolone; Myelitis, Transverse; Primary Dysautonomias; SARS-CoV-2; Spinal Cord | 2021 |
8 other study(ies) available for methylprednisolone and bromocriptine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Acute thrombotic accident in the postpartum period in a patient receiving bromocriptine.
Topics: Adult; Angiography; Bromocriptine; Carotid Artery Thrombosis; Carotid Artery, Internal; Heparin; Humans; Humerus; Male; Methylprednisolone; Postpartum Period; Thiopental; Thrombosis | 1990 |
Anti-NMDA Receptor Encephalitis in a Young Girl with Altered Behaviour and Abnormal Movements.
Topics: Adolescent; Amantadine; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies; Bromocriptine; Dyskinesias; Female; Humans; Leukocytosis; Methylprednisolone; Nervous System Diseases; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2018 |
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Topics: Adult; Audiometry, Pure-Tone; Bromocriptine; Cochlear Diseases; Diuretics; Furosemide; Glucocorticoids; Hearing Loss, Sensorineural; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Pituitary Neoplasms; Prolactinoma; Recurrence | 2019 |